This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated…
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology…
July 08, 2025 23:58 ET | Source: LQWD Technologies Corp. THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE…